David Gascoigne

David Gascoigne is the Chief Executive Officer at Almaden Genomics, where David leads the development of the g.nome™ platform. David has previously held leadership roles in companies like Sutherland, Gene Network Sciences, IQVIA, Symphony Health, Accenture, IMS Health, and Millward Brown, specializing in healthcare analytics, commercial analytics, marketing analytics, and statistical analysis.